Bliznakov, E G <br/><br/>
Lipid-lowering drugs (statins), cholesterol, and coenzyme Q10. The Baycol case--a modern Pandora's box.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Feb 2002 
 - 56-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0753-3322 
<br/><br/><label>Standard No.: </label>10.1016/s0753-3322(01)00150-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cardiovascular Diseases--prevention & control<br/>Cholesterol--metabolism<br/>Coenzymes<br/>Drug Synergism<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects<br/>Pyridines--adverse effects<br/>Rhabdomyolysis--chemically induced<br/>Ubiquinone--analogs & derivatives<br/>United States<br/>United States Food and Drug Administration--standards